Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 30

1.

Hyperphosphatemia and multiple myeloma: keep calm and control first.

Boud'hors C, Le Gallo M, Orvain C, Larcher F, Gardembas M, Augusto JF, Demiselle J.

Am J Med. 2019 Nov 9. pii: S0002-9343(19)30965-9. doi: 10.1016/j.amjmed.2019.10.022. [Epub ahead of print] No abstract available.

PMID:
31715167
2.

High-resolution copy number analysis of clear cell endometrial carcinoma.

O'Hara AJ, Le Gallo M, Rudd ML, Bell DW.

Cancer Genet. 2019 Oct 21;240:5-14. doi: 10.1016/j.cancergen.2019.10.005. [Epub ahead of print]

PMID:
31678638
3.

Serum CD95L Level Correlates with Tumor Immune Infiltration and Is a Positive Prognostic Marker for Advanced High-Grade Serous Ovarian Cancer.

De La Motte Rouge T, Corné J, Cauchois A, Le Boulch M, Poupon C, Henno S, Rioux-Leclercq N, Le Pabic E, Laviolle B, Catros V, Levêque J, Fautrel A, Le Gallo M, Legembre P, Lavoué V.

Mol Cancer Res. 2019 Dec;17(12):2537-2548. doi: 10.1158/1541-7786.MCR-19-0449. Epub 2019 Sep 19.

PMID:
31537619
4.

In-memory computing on a photonic platform.

Ríos C, Youngblood N, Cheng Z, Le Gallo M, Pernice WHP, Wright CD, Sebastian A, Bhaskaran H.

Sci Adv. 2019 Feb 15;5(2):eaau5759. doi: 10.1126/sciadv.aau5759. eCollection 2019 Feb.

5.

Neuromorphic computing with multi-memristive synapses.

Boybat I, Le Gallo M, Nandakumar SR, Moraitis T, Parnell T, Tuma T, Rajendran B, Leblebici Y, Sebastian A, Eleftheriou E.

Nat Commun. 2018 Jun 28;9(1):2514. doi: 10.1038/s41467-018-04933-y.

6.

Tumor analysis: freeze-thawing cycle of triple-negative breast cancer cells alters tumor CD24/CD44 profiles and the percentage of tumor-infiltrating immune cells.

Le Gallo M, de la Motte Rouge T, Poissonnier A, Lavoué V, Tas P, Leveque J, Godey F, Legembre P.

BMC Res Notes. 2018 Jun 20;11(1):401. doi: 10.1186/s13104-018-3504-5.

7.

Monatomic phase change memory.

Salinga M, Kersting B, Ronneberger I, Jonnalagadda VP, Vu XT, Le Gallo M, Giannopoulos I, Cojocaru-Mirédin O, Mazzarello R, Sebastian A.

Nat Mater. 2018 Aug;17(8):681-685. doi: 10.1038/s41563-018-0110-9. Epub 2018 Jun 18.

PMID:
29915424
8.

Memristive effects in oxygenated amorphous carbon nanodevices.

Bachmann TA, Koelmans WW, Jonnalagadda VP, Le Gallo M, Santini CA, Sebastian A, Eleftheriou E, Craciun MF, Wright CD.

Nanotechnology. 2018 Jan 19;29(3):035201. doi: 10.1088/1361-6528/aa9a18. Epub 2017 Dec 13.

PMID:
29235441
9.

Memristive Effects in Oxygenated Amorphous Carbon Nanodevices.

Bachmann T, Koelmans WW, Jonnalagadda P, Le Gallo M, Santini C, Sebastian A, Eleftheriou E, Craciun MF, Wright CD.

Nanotechnology. 2017 Nov 13. doi: 10.1088/1361-6528/aa9a18. [Epub ahead of print]

PMID:
29130890
10.

Temporal correlation detection using computational phase-change memory.

Sebastian A, Tuma T, Papandreou N, Le Gallo M, Kull L, Parnell T, Eleftheriou E.

Nat Commun. 2017 Oct 24;8(1):1115. doi: 10.1038/s41467-017-01481-9.

11.

CD95/Fas, Non-Apoptotic Signaling Pathways, and Kinases.

Le Gallo M, Poissonnier A, Blanco P, Legembre P.

Front Immunol. 2017 Sep 27;8:1216. doi: 10.3389/fimmu.2017.01216. eCollection 2017. Review.

12.

The FOXA2 transcription factor is frequently somatically mutated in uterine carcinosarcomas and carcinomas.

Le Gallo M, Rudd ML, Urick ME, Hansen NF; National Institutes of Health Intramural Sequencing Center Comparative Sequencing Program, Merino MJ, Mutch DG, Goodfellow PJ, Mullikin JC, Bell DW.

Cancer. 2018 Jan 1;124(1):65-73. doi: 10.1002/cncr.30971. Epub 2017 Sep 21.

13.

Somatic mutation profiles of clear cell endometrial tumors revealed by whole exome and targeted gene sequencing.

Le Gallo M, Rudd ML, Urick ME, Hansen NF, Zhang S; NISC Comparative Sequencing Program, Lozy F, Sgroi DC, Vidal Bel A, Matias-Guiu X, Broaddus RR, Lu KH, Levine DA, Mutch DG, Goodfellow PJ, Salvesen HB, Mullikin JC, Bell DW.

Cancer. 2017 Sep 1;123(17):3261-3268. doi: 10.1002/cncr.30745. Epub 2017 May 9.

14.

CD95 Stimulation with CD95L and DISC Analysis.

Le Gallo M, Legembre P.

Methods Mol Biol. 2017;1557:11-18. doi: 10.1007/978-1-4939-6780-3_2.

PMID:
28078578
15.

Next-Generation Sequencing.

Le Gallo M, Lozy F, Bell DW.

Adv Exp Med Biol. 2017;943:119-148. Review.

PMID:
27910067
16.

CD95-Mediated Calcium Signaling Promotes T Helper 17 Trafficking to Inflamed Organs in Lupus-Prone Mice.

Poissonnier A, Sanséau D, Le Gallo M, Malleter M, Levoin N, Viel R, Morere L, Penna A, Blanco P, Dupuy A, Poizeau F, Fautrel A, Seneschal J, Jouan F, Ritz J, Forcade E, Rioux N, Contin-Bordes C, Ducret T, Vacher AM, Barrow PA, Flynn RJ, Vacher P, Legembre P.

Immunity. 2016 Jul 19;45(1):209-23. doi: 10.1016/j.immuni.2016.06.028.

17.

Stochastic phase-change neurons.

Tuma T, Pantazi A, Le Gallo M, Sebastian A, Eleftheriou E.

Nat Nanotechnol. 2016 Aug;11(8):693-9. doi: 10.1038/nnano.2016.70. Epub 2016 May 16.

PMID:
27183057
18.

The mutational landscape of endometrial cancer.

Hong B, Le Gallo M, Bell DW.

Curr Opin Genet Dev. 2015 Feb;30:25-31. doi: 10.1016/j.gde.2014.12.004. Epub 2015 Jan 23. Review.

19.

Mutational analysis of the tyrosine kinome in serous and clear cell endometrial cancer uncovers rare somatic mutations in TNK2 and DDR1.

Rudd ML, Mohamed H, Price JC, O'Hara AJ, Le Gallo M, Urick ME; NISC Comparative Sequencing Program, Cruz P, Zhang S, Hansen NF, Godwin AK, Sgroi DC, Wolfsberg TG, Mullikin JC, Merino MJ, Bell DW.

BMC Cancer. 2014 Nov 26;14:884. doi: 10.1186/1471-2407-14-884.

20.

Crystal growth within a phase change memory cell.

Sebastian A, Le Gallo M, Krebs D.

Nat Commun. 2014 Jul 7;5:4314. doi: 10.1038/ncomms5314.

PMID:
25000349
21.

The emerging genomic landscape of endometrial cancer.

Le Gallo M, Bell DW.

Clin Chem. 2014 Jan;60(1):98-110. doi: 10.1373/clinchem.2013.205740. Epub 2013 Oct 29. Review.

22.

Sequencing of candidate chromosome instability genes in endometrial cancers reveals somatic mutations in ESCO1, CHTF18, and MRE11A.

Price JC, Pollock LM, Rudd ML, Fogoros SK, Mohamed H, Hanigan CL, Le Gallo M; NIH Intramural Sequencing Center (NISC) Comparative Sequencing Program, Zhang S, Cruz P, Cherukuri PF, Hansen NF, McManus KJ, Godwin AK, Sgroi DC, Mullikin JC, Merino MJ, Hieter P, Bell DW.

PLoS One. 2013 Jun 3;8(6):e63313. doi: 10.1371/journal.pone.0063313. Print 2014.

23.

Exome sequencing of serous endometrial tumors identifies recurrent somatic mutations in chromatin-remodeling and ubiquitin ligase complex genes.

Le Gallo M, O'Hara AJ, Rudd ML, Urick ME, Hansen NF, O'Neil NJ, Price JC, Zhang S, England BM, Godwin AK, Sgroi DC; NIH Intramural Sequencing Center (NISC) Comparative Sequencing Program, Hieter P, Mullikin JC, Merino MJ, Bell DW.

Nat Genet. 2012 Dec;44(12):1310-5. doi: 10.1038/ng.2455. Epub 2012 Oct 28.

24.

PNPLA1 mutations cause autosomal recessive congenital ichthyosis in golden retriever dogs and humans.

Grall A, Guaguère E, Planchais S, Grond S, Bourrat E, Hausser I, Hitte C, Le Gallo M, Derbois C, Kim GJ, Lagoutte L, Degorce-Rubiales F, Radner FP, Thomas A, Küry S, Bensignor E, Fontaine J, Pin D, Zimmermann R, Zechner R, Lathrop M, Galibert F, André C, Fischer J.

Nat Genet. 2012 Jan 15;44(2):140-7. doi: 10.1038/ng.1056.

PMID:
22246504
25.

HLA-A*0201-restricted CEA-derived peptide CAP1 is not a suitable target for T-cell-based immunotherapy.

Fauquembergue E, Toutirais O, Tougeron D, Drouet A, Le Gallo M, Desille M, Cabillic F, de La Pintière CT, Iero M, Rivoltini L, Baert-Desurmont S, Leprince J, Vaudry H, Sesboué R, Frébourg T, Latouche JB, Catros V.

J Immunother. 2010 May;33(4):402-13. doi: 10.1097/CJI.0b013e3181d366da.

PMID:
20386466
26.

DNAX accessory molecule-1 (CD226) promotes human hepatocellular carcinoma cell lysis by Vgamma9Vdelta2 T cells.

Toutirais O, Cabillic F, Le Friec G, Salot S, Loyer P, Le Gallo M, Desille M, de La Pintière CT, Daniel P, Bouet F, Catros V.

Eur J Immunol. 2009 May;39(5):1361-8. doi: 10.1002/eji.200838409.

27.

Activation of tumor-specific T cells by dendritic cells expressing the NY-ESO-1 antigen after transfection with the cationic lipophosphoramide KLN5.

Le Gallo M, Toutirais O, Montier T, Cabillic F, Bouet F, Delépine P, Lehn P, Jotereau F, Catros V.

J Gene Med. 2008 Jun;10(6):628-36. doi: 10.1002/jgm.1188.

PMID:
18338820
28.

Vgamma9Vdelta2 T cell-mediated recognition of human solid tumors. Potential for immunotherapy of hepatocellular and colorectal carcinomas.

Bouet-Toussaint F, Cabillic F, Toutirais O, Le Gallo M, Thomas de la Pintière C, Daniel P, Genetet N, Meunier B, Dupont-Bierre E, Boudjema K, Catros V.

Cancer Immunol Immunother. 2008 Apr;57(4):531-9. Epub 2007 Sep 1.

PMID:
17764010
29.

Effects of CD40 binding on ovarian carcinoma cell growth and cytokine production in vitro.

Toutirais O, Gervais A, Cabillic F, Le Gallo M, Coudrais A, Levêque J, Catros-Quemener V, Genetet N.

Clin Exp Immunol. 2007 Aug;149(2):372-7. Epub 2007 Jun 12.

30.

Identification of a new locus for isolated familial keratoconus at 2p24.

Hutchings H, Ginisty H, Le Gallo M, Levy D, Stoësser F, Rouland JF, Arné JL, Lalaux MH, Calvas P, Roth MP, Hovnanian A, Malecaze F.

J Med Genet. 2005 Jan;42(1):88-94. No abstract available.

Supplemental Content

Loading ...
Support Center